Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

63.40
+4.758.10%
Post-market: 64.511.11+1.75%19:52 EDT
Volume:147.30K
Turnover:9.09M
Market Cap:182.21M
PE:-1.65
High:64.15
Open:58.82
Low:58.00
Close:58.65
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.93
T/O Rate:6.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:2.18
PE(LYR):-1.25

Loading ...

Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.d., as Vice President, Clinical Development

THOMSON REUTERS
·
Aug 03

Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus

TIPRANKS
·
Jul 31

Spruce Biosciences Files Form 3 for Chief Medical Officer Adrian W. Quartel

Reuters
·
Jul 30

Spruce Biosciences Names Adrian Quartel Chief Medical Officer

Reuters
·
Jul 27

Spruce Biosciences Appoints Adrian Quartel, M.d., Ffpm, as Chief Medical Officer

THOMSON REUTERS
·
Jul 27

Spruce Biosciences Initiated at Buy by B. Riley Securities

Dow Jones
·
Jul 13

B. Riley Initiates Spruce Biosciences at Buy With $160 Price Target

MT Newswires Live
·
Jul 13

Spruce Biosciences, Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $160

THOMSON REUTERS
·
Jul 13

Spruce Biosciences joins Russell 3000 Index

TIPRANKS
·
Jun 29

Spruce Biosciences names Agnieszka Jurecka vice president, medical affairs

Reuters
·
Jun 22

Spruce Biosciences Appoints Agnieszka Jurecka, M.d., Ph.d., Mph, as Vice President, Medical Affairs

THOMSON REUTERS
·
Jun 22

Spruce Biosciences Initiated at Buy by Guggenheim

Dow Jones
·
Jun 16

Spruce Biosciences names Eric Jordan as VP, Marketing

Reuters
·
Jun 15

Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller

THOMSON REUTERS
·
Jun 15

Spruce Biosciences Initiated at Buy by Jones Trading

Dow Jones
·
Jun 09

Spruce Biosciences Reports Long-Term Data for Enzyme Replacement Therapy to Treat Genetic Disease MPS IIIB

MT Newswires Live
·
Jun 09

Spruce Biosciences initiated with a Buy at JonesResearch

TIPRANKS
·
Jun 09

Spruce says long-term TA-ERT data presented at MPS Symposium

TIPRANKS
·
Jun 09

Spruce Biosciences reports six-year tralesinidase alfa data showing sustained biomarker reductions, stabilized cognition in MPS IIIB

Reuters
·
Jun 09

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (Mps Iiib) Presented at the 18TH International Mps Symposium

THOMSON REUTERS
·
Jun 09